Health Condition 1: L20- Atopic dermatitis
Conditions
Interventions
Intervention1: Homoeopathic Medicine: Pill form
30 pill size
Oral route of administration
Centesimal scale
First dose at the time of case taking
Subsequent doses according to follow up for a period of
Sponsors
Bakson Homoeopathic Medical College And Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Participants aged between 18 and 59 years. Diagnosed cases of Atopic Dermatitis by Hanifin and Rajka criteria. Participants already on allopathic medication/topical agents for Atopic Dermatitis will be included after 15 days of washout period.
Exclusion criteria
Exclusion criteria: Participants with other severe dermatological conditions or autoimmune diseases. Participants suffering from any severe systemic illness , immuno-compromised conditions, severe psychiatric issues. Pregnant or lactating women. Participants who are not able to comply to the study protocol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that there will be improvement in Dermatology Life Quality Index (DLQI) scale indicating better quality of lifeTimepoint: 15 month study. 6 months enrolment 6 months follow up 3 months analysis Dermatology Life Quality Index (DLQI) scale will be assesses at baseline and after 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that there will be reduction in the Eczema Area and Severity Index score from baseline to the end of the study periodTimepoint: 15 month study. 6 months enrolment 6 months follow up 3 months analysis Eczema Area and Severity Index (EASI) Scale will be assessed at baseline and after 6 months | — |
Countries
India
Contacts
Public ContactDR AKSHAY MATHUR
Bakson Homoeopathic Medical College and Hospital
Outcome results
None listed